A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms

This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated.

Year

1999

Language

English

Publisher

National Academies Press

Editions

1

ISBN

9780309583015

Data source: Wikidata